Panel Discussion: Exploring More Objective Ways of Classifying IBD Subtypes to Improve Patient Stratification

Time: 11:00 am
day: Day One


A session dedicated to discussing the future of risk-classifying IBD patients and tackling the need for more objective classifications.

  • Discovering genetic signatures, microbiome patterns and proteomic indicators to formulate more homogenous patient groups to increase therapeutic efficacy within that patient group
  • Exploring novel scores to effectively measure burden of disease to better understand the patient need to inform therapeutic decisions
  • Addressing inconsistencies within the field regarding categorization of IBD subtypes to ensure novel discoveries are applicable across clinical settings